Table 1 Patient characteristicsa
From: Acute respiratory failure in kidney transplant recipients: a multicenter study
Demographics | All patients (N= 200) | Hospital survivors (n= 155) | Hospital deaths (n= 45) | P value |
|---|---|---|---|---|
Median age, yr (25th to 75th percentile) | 56 (46 to 65) | 55 (44 to 64) | 61 (52 to 67) | 0.06 |
Male sex, n (%) | 123 (61.5) | 97 (62.6) | 26 (57.8) | 0.60 |
Comorbidities, n (%) | ||||
Hypertension | 164 (82.8) | 130 (85) | 35 (75.7) | 0.18 |
Heart failure | 93 (46.7) | 73 (47.4) | 20 (44.4) | 0.74 |
Diabetes mellitus | 55 (27.6) | 41 (26.6) | 14 (31.1) | 0.57 |
Causes of end-stage renal disease, n (%) | 0.7 | |||
Glomerulonephritis | 52 (26) | 41 (26.5) | 11 (24.4) | |
Diabetes mellitus | 29 (14.5) | 21 (13.5) | 8 (17.8) | |
Nephroangiosclerosis | 24 (12) | 19 (12.3) | 5 (11.1) | |
Polycystic kidney disease | 20 (10) | 13 (8.4) | 7 (15.6) | |
Uropathy | 14 (7) | 12 (7.7) | 2 (4.4) | |
Other or undetermined | 61 (30.5) | 49 (31.6) | 12 (26.7) | |
Characteristics of the transplantation, n (%) | 0.28 | |||
First kidney allograft | 147 (73.5) | 116 (74.8) | 31 (68.9) | |
Kidney retransplantation | 38 (19) | 26 (16.8) | 12 (26.7) | |
Combined kidney-pancreas | 15 (7.5) | 13 (8.4) | 2 (4.4) | |
Cadaver/living donor | 190/8 (96/4) | 148/7 (95.5/4.5) | 44/1 (97.8/2.2) | 0.69 |
Immunosuppressive regimen, n (%) | ||||
Cyclosporine | 98 (50) | 78 (51.3) | 20 (45.5) | 0.61 |
Tacrolimus | 71 (36) | 54 (35.3) | 17 (38.6) | 0.72 |
Mycophenolate mofetil | 139 (71.6) | 110 (72.8) | 29 (67.4) | 0.57 |
Sirolimus | 25 (12.8) | 21 (13.9) | 4 (9.1) | 0.61 |
Azathioprine | 24 (12.2) | 17 (11.2) | 7 (15.9) | 0.44 |
Steroids | 170 (86.7) | 132 (86.8) | 38 (86.4) | > 0.99 |
Acute rejection, n (%) | 43 (21.5) | 34 (21.9) | 9 (20) | 0.84 |
Cytomegalovirus disease, n (%) | 37 (19.4) | 27 (18.4) | 10 (22.7) | 0.52 |